Molecular residual disease detection with circulating tumor DNA analysis predicts relapse in patients with early stage breast cancer

被引：0
|
作者：
Turner, N.
Garcia-Murillas, I.
Chopra, N.
Comino-Mendez, I.
Beaney, M.
Tovey, H.
Cutts, R.
Swift, C.
Kriplani, D.
Afentakis, M.
Hrebien, S.
Walsh, G.
Johnston, S.
Ring, A.
Russell, S.
Evans, A.
Skene, A.
Wheatley, D.
Dowsett, M.
Smith, I.
机构：
[1] Inst Canc Res, London, England
[2] Royal Marsden Hosp, London, England
[3] Hinchingbrooke Hosp, Hungtindon, England
[4] Poole Gen Hosp, Poole, Dorset, England
[5] Royal Bournemouth Hosp, Bournemouth, Dorset, England
[6] Royal Cornwall Hosp NHS Trust, Truro, England
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P4-01-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-01-01
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Circulating tumor DNA-based molecular residual disease predicts relapse in patients with resectable gastric cancer
    Xue, Pei
    Shao, Yanfei
    Zhou, Xueliang
    Li, Haiyan
    Wang, Yang
    Wang, Chenyang
    Zhang, Hao
    Li, Bing
    Shi, Shuo
    Du, Haiwei
    Sun, Jing
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
    Garcia-Murillas, Isaac
    Schiavon, Gaia
    Weigelt, Britta
    Ng, Charlotte
    Hrebien, Sarah
    Cutts, Rosalind J.
    Cheang, Maggie
    Osin, Peter
    Nerurkar, Ashutosh
    Kozarewa, Iwanka
    Garrido, Javier Armisen
    Dowsett, Mitch
    Reis-Filho, Jorge S.
    Smith, Ian E.
    Turner, Nicholas C.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (302)
  • [3] Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer
    Coakley, Maria
    Villacampa, Guillermo
    Sritharan, Prithika
    Swift, Claire
    Dunne, Kathryn
    Kilburn, Lucy
    Goddard, Katie
    Pipinikas, Christodoulos
    Rojas, Patricia
    Emmett, Warren
    Hall, Peter
    Harper-Wynne, Catherine
    Hickish, Tamas
    Macpherson, Iain
    Okines, Alicia
    Wardley, Andrew
    Wheatley, Duncan
    Waters, Simon
    Palmieri, Carlo
    Winter, Matthew
    Cutts, Rosalind J.
    Garcia-Murillas, Isaac
    Bliss, Judith
    Turner, Nicholas C.
    CLINICAL CANCER RESEARCH, 2024, 30 (04) : 895 - 903
  • [4] Circulating tumor DNA (ctDNA) for detection of molecular residual disease (MoRD) in breast cancer
    Austin, L.
    Jaslow, R.
    Fortina, P.
    Nagy, R.
    Zill, O.
    Talasaz, A.
    Cristofanilli, M.
    CANCER RESEARCH, 2016, 76
  • [5] Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
    Tie, Jeanne
    Wang, Yuxuan
    Tomasetti, Cristian
    Li, Lu
    Springer, Simeon
    Kinde, Isaac
    Silliman, Natalie
    Tacey, Mark
    Wong, Hui-Li
    Christie, Michael
    Kosmider, Suzanne
    Skinner, Iain
    Wong, Rachel
    Steel, Malcolm
    Tran, Ben
    Desai, Jayesh
    Jones, Ian
    Haydon, Andrew
    Hayes, Theresa
    Price, Tim J.
    Strausberg, Robert L.
    Diaz, Luis A., Jr.
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (346)
  • [6] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Bagegni, Nusayba A.
    Ademuyiwa, Foluso O.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (04) : 356 - 363
  • [7] Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
    Chaudhuri, Aadel A.
    Chabon, Jacob J.
    Lovejoy, Alexander F.
    Newman, Aaron M.
    Stehr, Henning
    Azad, Tej D.
    Khodadoust, Michael S.
    Esfahani, Mohammad Shahrokh
    Liu, Chih Long
    Zhou, Li
    Scherer, Florian
    Kurtz, David M.
    Say, Carmen
    Carter, Justin N.
    Merriott, David J.
    Dudley, Jonathan C.
    Binkley, Michael S.
    Modlin, Leslie
    Padda, Sukhmani K.
    Gensheimer, Michael F.
    West, Robert B.
    Shrager, Joseph B.
    Neal, Joel W.
    Wakelee, Heather A.
    Loo, Billy W., Jr.
    Alizadeh, Ash A.
    Diehn, Maximilian
    CANCER DISCOVERY, 2017, 7 (12) : 1394 - 1403
  • [8] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Nusayba A. Bagegni
    Foluso O. Ademuyiwa
    Current Breast Cancer Reports, 2023, 15 : 356 - 363
  • [9] Circulating Tumor DNA for Monitoring Minimal Residual Disease and Early Detection of Recurrence in Early Stage Lung Cancer
    Tan, A.
    Lai, G.
    Saw, S.
    Chua, K.
    Takano, A.
    Ong, B.
    Koh, T.
    Jain, A.
    Tan, W.
    Ng, Q.
    Kanesvaran, R.
    Rajasekaran, T.
    Kalshnikova, E.
    Shchegrova, S.
    Ta, H.
    Lin, J.
    Renner, D.
    Sethi, H.
    Zimmermann, B.
    Aleshin, A.
    Lim, W.
    Tan, E.
    Skanderup, A.
    Ang, M.
    Tan, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S907 - S907
  • [10] Early detection of circulating tumor DNA for the assessment of resistance or relapse to neoadjuvant chemotherapy in breast cancer patients
    Isnaldi, E.
    Ferrando, L.
    Garuti, A.
    Cirmena, G.
    Franceschelli, P.
    Fregatti, P.
    Garlaschi, A.
    Friendman, D.
    Ballestrero, A.
    Zoppoli, G.
    ANNALS OF ONCOLOGY, 2017, 28 : 5 - 5
12345